Table 2.
2a: No change in simulation technique | |||
---|---|---|---|
Mean (SD) (min–max) | p-value | ||
GTV (cc) | First scan | 276.7(253.8) (4.8–933) | 0.001 |
Second scan | 192.7 (180) (2.4–733) | ||
Lung volume (cc) | First scan | 3700 (1085) (1791–6540) | 0.064 |
Second scan | 3833 (1046) (1313–6145) | ||
PTV D95 (%) | First scan | 94.99 (4.04) (84–99.7) | 0.38 |
Second scan | 94.52 (4.9) (80–99.7) | ||
Lung V20 (%) | First scan | 26 (7.6) (0.8–39) | 0.36 |
Second scan | 25.3 (6.6) (9.7–37) | ||
Mean lung dose (Gy) | First scan | 15.1 (3.7) (3–22.5) | 0.23 |
Second scan | 14.7 (3.3)5–21 | ||
Heart V40 (%) | First scan | 10.2 (13) (0–64) | 0.037 |
Second scan | 7.2 (9.8) (0–45) | ||
Spine maximal dose (Gy) | First scan | 39 (8.4) (19.6–50.7) | 0.72 |
Second scan | 39.2 (8.8) (21-52) | ||
2b: With change in simulation technique | |||
Mean (SD) (min-max) | p-value | ||
GTV (cc) | First scan | 165.8 (161) (9.3–480) | 0.13 |
Second scan | 131 (126) (3.3–349) | ||
Lung volume (cc) | First scan | 2835.8 (1062) (1613–5300) | 0.001 |
Second scan | 4466 (1250)(2567–6838) | ||
PTV D95 (%) | First scan | 92.2 (4.9) (84-98) | 0.72 |
Second scan | 93.3 (6.5) (79-99) | ||
Lung V20 (%) | First scan | 30.8 (8.2) (8–37.5) | 0.012 |
Second scan | 27.3 (8) (4–36.5) | ||
Mean lung dose (Gy) | First scan | 17.3 (4.4) (5.6–22.6) | 0.007 |
Second scan | 15.3 (3.8) (3–18.8 | ||
Heart V40 (%) | First scan | 11.1 (14.7) (0–51) | 0.014 |
Second scan | 6.5 (6.7) (0–19) | ||
Spine maximal dose (Gy) | First scan | 46.6 (8.4 (31.7–60) | 0.028 |
Second scan | 39.4 (7.9) (26.8–50.3) |
GTV, Gross tumor volume; Gy, radiation units in Gray; LungV20, lung volume receiving above 20 Gy; PTV, Planning Target Volume; SD, standard deviation.
D95 volume covered by 95% of the dose; Heart V 40-heart volume receiving dose above 40 Gy. Dose if plan was to the full prescribed dose with the current scan. For p-value Wilcoxon signed-rank test was used.